Alpha DNA Investment Management’s Qfin Holdings QFIN Stock Holding History

Alpha DNA Investment Management’s Portfolio QFIN Stock Details QFIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-117	Closed	-$3K	–	516
2021 Q1	$3K	Buy	+117	New	+$2.61K	﹤0.01%	506

Other funds holding QFIN

FCCPG

FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.25B AUM 18.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

TIAM

TT International Asset Management London, United Kingdom $783M AUM 104.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GDWAM

Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

GAMH

Greenwoods Asset Management (HK) Hong Kong $2.19B AUM 50.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Alpha DNA Investment Management's QFIN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Qfin Holdings (QFIN) in Q2 2021, closing a stake of 117 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in QFIN in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 172 funds tracked by Wall St. Rank hold QFIN as of Q2 2021.

Alpha DNA Investment Management reported no remaining Qfin Holdings position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 117 Qfin Holdings shares in Q2 2021, an estimated $3K.
Alpha DNA Investment Management first reported a position in Qfin Holdings in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Qfin Holdings position peaked at $3K in Q1 2021.
172 funds tracked by Wall St. Rank held Qfin Holdings as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.